Team

Analyzes and assesses promising ventures. With a background in microeconomics, econometrics, and business, and an interest in choice architecture, he understands and interprets the patient and market value of NLC ventures in light of critical gaps in the healthcare sector.

Anemone supports NLC as a Venture developer, holding a medical degree and a Bachelor in Business Administration. An open-minded and enthusiastic team-player driven by her interest in healthcare and improving patients’ lives.

Passionate about making an impact by improving healthcare for everyone. Annemieke has over six years of experience in healthcare strategy consulting. She holds two master’s degrees, combining science with business management.  At NLC, she focuses on venture development and business development.

Currently partner of Ownership Capital. Over 20 years of experience in investment management and responsible investing and private equity. (Senior investment director at PGGM, various senior positions at ABN AMRO)

Founder of NLC with a personal aim to advance health. He has over twenty years of experience in business development and growth strategies. His love for pushing boundaries and stretching the possibilities of an organization allows Bert-Arjan to steer NLC's unique business model and to support the team.

Brendan Bank helps NLC to develop our data and decision platforms, which are an important foundation for scaling up NLC’s venture building. Brendan was (among other things) CTO of Booking.com, where he grew the technology team from 30 engineers and product managers to around 1700.

Currently a student at Saxion Hogeschool, following Business and IT bachelor study. He has a completed bachelor study in Finances. Strives to help business achieve optimal IT support, improve ICT workflow, translate business requirements into IT solutions, and optimize business processes. Strives to develop effective and efficient IT support, so that the enterprise achieves its goals and objectives.

Cardio and Neuro Vascular expert, with 30 years experience in executive roles in the medical device industry in Europe.

Broad international management background in Medtech and Consumer healthcare solutions: understands what it takes to turn ideas into practice. Dirk is an advisory board member of several life sciences companies and has his own consultancy firm.

Entrepreneurial, positive and result-driven team player with a decade of experience in talent management and executive search, including founding and exiting a life sciences recruitment agency. Passionate about high-impact innovation and strong believer of ‘You can invent alone, but you can not innovate alone’.

Pharmaceutical executive with over 18 years of successful practice in different, international work settings (large pharma, biotech start-up, pharma management consultancy) performing hands-on corporate tasks (Operations, BusDev./licensing, fundraising, org).

Extensive experience in international banking and finance as well as investment banking (ABN AMRO and Mees & Hope). Over 20 years working for LMS International NV, a software engineering company - being engaged in finance and related matters

Pivotal role in building and developing a venture capital backed company (BMEYE, spin-off from TNO) and its sale to Edwards Lifesciences for €32.5M. Proven track record as finance executive in life sciences in international corporate environment (Organon Teknika, Organon, Schering-Plough). Successful interim assignments at private equity backed companies (Ampelmann, PitPoint clean fuels) and at Quby. MSc. Economics & Executive Master of Finance & Control

Gabe currently studies biomedical engineering and computer science at the University of Virginia. He is excited to apply his interdisciplinary background to NLC’s scouting and selection stages and help play a role in furthering innovation in the healthtech world.

Gina holds a Masters in biotechnology with a focus on synthetic biology from ETH Zurich and worked in management consulting as well as venture capital before joining NLC. She joined NLC as a Venture Developer in February 2020 to help startups succeed and ensure the wealth of innovation surrounding us gets its chance to make a real impact.

Dedicated team player with a masters in Molecular and Cellular Life Sciences. With a passion for helping others in need, she likes the combination of using her background and entrepreneurship to bring new technologies to patients.

Hidde has extensive experience in mergers & acquistions, corporate and structured finance, company valuations, debt advisory, venture capital and treasury management. He gained this experience at EY’s M&A department, at Zanders as well as at an Amsterdam based M&A boutique. He will use this experience to help NLC’s ventures with finance related issues throughout their lifecycle under NLC’s management, ultimately leading to achieving successful exits, maximizing the ventures’ positive impact on society.  

Business legal counsel with multidisciplinary/dynamic profile and more than 9 years of experience in corporate law, real estate law, tax law, and general contracts, having worked in structured deals in the real estate market, including mergers and acquisitions (M&A) transactions. Igor is a team player who holds a master's degree in International Business Law from Tilburg University and strongly believes in the growth of businesses focused on making a high positive impact on society and the environment as a fundamental tool for social transformation and also for the development in the way people do business around the world.

An experienced international executive recruiter with five years of experience within Healthtech.

Business lawyer and former Senior Vice President at Royal Philips, where he has during a career of almost 30 years held various leadership positions within its law department, i.a. as general counsel of Philips’ consumer products division. He has gained a broad experience in a variety of business/corporate legal matters, with a special focus on M&A in an international context. As a member of international management teams, he gained hands-on experience in various business processes and strategic decision-making.

Over 20 years of experience in the healthcare sector. Several functions at Merck and Johnson & Johnson. CEO (Novadel, OctoPlus, besides  this investments advisor for 3i (private equity) and held over 10 executive and non-executive supervisory board positions.

Ji Zhang holds Bachelor and Master degrees in Material Science and Engineering from University of Science and Technology Beijing and MBA from Rotterdam School of Management. Ji had 10 years experience in entrepreneurship, consulting, business development, sales and marketing, and now he joined NLC as a business developer to help it bring science to life and explore its China Strategy.

Responsible for guarding the quality of inflow of new technologies. She holds a Msc in Life Sciences and Innovation management.  With her multidisciplinary interests, she is always keen to spot opportunities and select technologies ready for venture building. A team player determined to strengthen the venture development team and venture building process.

Leads NLC’s operations, using his hands-on experience with developing young, fast growing companies. Joost holds an MSc. in Theoretical Physics and provided board level consulting for 20 years, among others as managing partner of healthcare specialist Plexus (later KPMG Plexus, after the acquisition he negotiated).

Koen is currently a master student of Technical Medicine, specializing in medical imaging and interventions. An ambitious, enthusiastic team-player who is eager to combine his clinical expertise and technological insight in order to bring promising technologies closer to the patient. He will enable this by supporting the Venture Developers at NLC.

Driven by the goal of making a positive societal impact through entrepreneurship, Lars joined NLC after finishing my master's degree at the London School of Economics. Together with the rest of the Venture Finance team, he is responsible for designing and validating business models of our new healthtech ventures, managing financing rounds for ventures in the NLC portfolio (both dilutive and non-dilutive), and developing novel financial propositions to ensure all our portfolio companies are financed according to need. This is all done with one single goal in mind: to accelerate the growth of NLC's venture portfolio and bring more groundbreaking medical innovations to the patient.

Lily joined NLC in March 2020 as a Venture Finance Intern. She is a nurse with a passion for finance. She recently graduated with a Master's degree in Finance and Investment from Rotterdam School of Management. Before joining NLC, she interned at ABN AMRO Risk Management. She is attracted by NLC’s entrepreneurship and with her keen interest in both healthcare and finance, she is eager to help ventures in financial matters together with her medical professional background.

An enthusiastic team player with the ambition to bridge the gap between technologies and healthcare. She has a masters in Technical Medicine, Imaging and Interventions. Eager to bring fantastic innovations to the patient and drive fundamental change and improvements in healthcare. She is going to achieve this by supporting NLC as a Venture Developer.

Lou is a business minded corporate legal counsel with extensive international experience in major law firms in Luxembourg and New York. She enjoys working in a thriving environment and aims to contribute her legal expertise to make a significant impact on healthcare.  She will be providing legal support to both NLC and its ventures.

Lucia joined NLC in December 2019 as a Venture Developer Intern, after having finished her Bachelor’s degree in Biomedical Engineering.  She studied at the Universidad Politécnica de Valencia (UPV) in Spain, where she is from. She completed the last semester of her studies at Michigan Technological University and did an internship at the Center for Arrhythmia Research at University of Michigan. Very enthusiastic about gaining experience, she’s willing to learn the most from NLC and help to bring closer the scientific and clinical worlds.

Entrepreneur with more than 30 years experience in building global businesses, developing and executing growth strategies mainly in healthcare including mergers and acquisitions. Built businesses within corporates (Fujitsu, Philips Speech Processing,  Nuance Communications) as well as through co-founding or investing in start-ups such as Superevent, Telecats Austria, ESR iGuide, contextflow and NLC.

At NLC, Marcelo works in the venture development and venture support functional areas. Prior to NLC, Marcelo worked in the pharmaceutical and biotechnology industries in product launch and marketing positions across both therapeutics and diagnostics. He holds a Masters in Public Health with a concentration in health economics and an MBA.

Over 20 years experience in online and database strategies, including multipe years on board level. Driven to bridge the gap between technical solutions and business needs. Excited to help NLC use their extended network to bring science to life.

Mart is a Master’s student in Science and Business Management and he is currently doing a Venture Development graduate internship for 5 months (Feb-July). He aims to translate his knowledge and expertise in medical biology and business economics into building impactful healthtech ventures. Mart is eager to support disruptive medical innovations which benefit patients’ lives.

Driven, internationally oriented generalist aiming at having a positive impact for people and society. As a Venture Services Manager, he is providing services to scale NLC’s ventures to bring innovation to healthcare and to improve people’s lives. He holds an MA in International Relations from the University of Groningen and an MBA from INSEAD.

Pharmacist by training and with various entrepreneurial endeavours during his studies he acquired the skills to bring projects forward. Therefore, he is very eager to use these skills to bring technology, health and business together to drive change and innovation for the patient.

Responsible for NLC’s corporate partnerships. She believes constructive collaboration is a true prerequisite for value creation. Nina loves to build new concepts and stories together with people and feels privileged to work in an environment where people not only dare to envision the future, but also help shape it.

Prior to joining NLC as a Venture Partner, Pieter spent 15 years at Philips, bringing innovation to life across the globe. He enjoys working in fast paced environments and supporting initiatives that truly improve the lives of people.

I am an enthusiastic Innovation Sciences master student at the Utrecht University. I will be a venture development intern at NLC for 7 months (june-december 2020) while writing my thesis for one of the ventures. I am both Dutch and Belgian, studied one year International Business at the University of Iowa, and finished a Bachelor in Innovation Sciences at the Utrecht University. I have a large interest in innovation processes and life sciences. I am eager to learn more about NLC, and super excited to help bring more healthtech innovations to the patients.

Cardiovascular/Thoracic Surgeon Associate Professor in cardiac surgery

Professor in cardiac surgery. Head of Center for Biomadical Research Medical University Vienna

Cardiac Surgeon Professor in cardiac surgery University Hospital Basel

Highly motivated technology enthusiast with a passion for making processes more fluent and integrated, Raymond will be managing the ICT Systems and working with a small team to improve our current ICT related workflows.

Currently studying a Masters degree in Bioinformatics and Biostatistics, focused in Computational Genomics and Data Analysis. He holds a Bachelors degree in Biology with a specialization in genetics. Roberto  will be working with the ICT team as ICT employee.

Trained as a Pharmacist, he worked in several pharmaceutical companies and has broad experience in marketing and sales functions as well as general management.  As Venture Partner his focus is on building innovative companies and strengthening NLC’s abilities to bring innovations to healthcare.

Before joining NLC, spent 6 years at Robeco Asset Management and almost 14 years in KPMG’s Deals practice, of which the last 6.5 years as a Partner. Ruben brings along a lot of expertise in general financial management and M&A. He is looking forward to use his experience to support NLC with its expansion plans.

Former Chief IP Officer and Executive Vice President at Philips. IP business leader and entrepreneur, widely recognized as one of the current thought leaders in IP.

Hands on with extensive experience in office management, project management and marketing support in the healthcare sector. Gets energy from arranging everything down to the last detail.

Highly motivated, passionate proactive team player with a great sense of responsibility. She likes the combination of Finance and Legal tasks that contribute to the development of the company and bringing science to life.

Corporate counsel with around 18 years of international experience in the life sciences and chemical industry, who is driven by “making things happen” at innovative companies, with the aim to make a social impact. She has held various inhouse positions at DSM (Life Science & Innovation Cluster) and recently at Avantium’s joint venture Synvina. At NLC, she will be providing and managing legal support to both NLC and its ventures, and as such contributing to bring science to life.

Experienced MedTech executive with ample experience in fund-raising and creating and growing MedTech companies for complex Class III medical devices (including Sapiens Steering Brain Stimulation, acquired by Medtronic, and GTX medical). Over 25 years of experience in R&D project management, product management, creating and managing alliances, and early stage venturing, mainly for MedTech and Healthcare products.

Sven joined NLC in June 2020 as a Venture Finance Intern. He recently obtained his Bachelor degree in Economics and Law from the University of Münster in Germany. He is highly interested in Finance and M&A and was able to gain experience on this area during his internship in Transaction Services at Deloitte. By supporting healthtech ventures in financial matters, he is dedicated to make a positive impact.

A highly international and networked entrepreneur trained as Medical Doctor and Medical Biologist, he is a visionary strategist conversant within and across disciplines. As Venture Partner, his focus is on building innovative companies and strengthening NLC’s abilities to bring innovations to healthcare.

Financial, legal and entrepreneurial generalist

Tom has extensive experience in raising debt & capital funding for mid-market Private Equity, Private Corporates, and fast-growing ventures (e.g. scale-ups). He gained this experience over the past 8 years at Deloitte’s Debt & Capital Advisory practice in Amsterdam and London. He will leverage this experience to support NLC’s ventures with finance related issues throughout their lifecycle under NLC’s management, ultimately leading to achieving successful exits, maximizing the ventures’ positive impact on society.  

Wessel van Dijk was, among other things, Managing Director at Johnson & Johnson where he led the EMEA integration of Synthes and board member of Nefemed.

Responsible for overseeing all technical aspects of NLC at an operational and strategic level. Guarding the quality of inflow and driving supporting technologies. PhD with both corporate and venturing experience, as principal scientist and prolific inventor at Philips Research turned serial entrepreneur.  IP-expert. Fascinated by nature, technology and their synergy.

Willemijne is a Venture Developer Intern and is currently busy with here Master Technical Medicine in Delft/Leiden/Rotterdam after finishing a Bachelor in Clinical Technology. Her big interest in both technology and healthcare and adding innovation creates the perfect combination at NLC! Her goal is to focus on scouting and selecting valuable inventions to help more patients and improve healthcare.